Abbott India Ltd
The live share price of Abbott India Ltd (ABBOTINDIA) as on 08 Dec 10:23am is ₹22,858 from NSE/BSE.
ABBOTINDIA NSE
₹22,858 ▼-0.93% (-215.4)
As on Dec 08, 2023 03:53 PM IST
Key Metrics
PE Ratio
45.34
PB Ratio
15.38
Dividend Yield
1.41%
Sector PB
5.11
Sector PE
44.48
Sector Div Yld
0.7%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Abbott India is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
The following charts display the financial performance of the Abbott India Ltd (ABBOTINDIA) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Abbott India Ltd (ABBOTINDIA), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Financials
Income Statement
(INR) | Y/Y Change | |
Revenue | 5,533 Cr | +10.32% |
Operating Expense | 216 Cr | +83.53% |
Net Income | 949 Cr | +18.87% |
Net Profit Margin | 17.16% | +7.79% |
Earning Per Share | 446 | +18.87% |
EBITDA | 1,359 Cr | +16.73% |
Balance sheet
(INR) | Y/Y Change | |
Cash & short-term Inv | 1,937 Cr | -29.54% |
Total Assets | 4,555 Cr | +7.85% |
Total Liabilities | 1,366 Cr | -2.66% |
Total Equity | 3,188 Cr | +13.08% |
Shares Outstanding | 2.12 Cr | -0.23% |
Price to Book | 14.7 | +11.39% |
Return on Assets | 21.63% | +9.19% |
Return on Capital | 40.45 Cr | +3.8% |
Cash Flows
(INR) | Y/Y Change | |
Net Income | 949 Cr | +18.87% |
Cash from Operations | 893 Cr | -5.73% |
Cash from Investing | -147 Cr | -62.68% |
Cash from Financing | -638 Cr | +0.21% |
Net Change in Cash | 106 Cr | -225.01% |
Free Cash Flow | 859 Cr | -4.9% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
34.78
1Y Return
▲26%
CIPLA
Cipla Ltd
PE Ratio
28.59
1Y Return
▲10.08%
DRREDDY
Dr Reddy's Laboratories Ltd
PE Ratio
18.92
1Y Return
▲32.31%
MANKIND
Mankind Pharma Ltd
PE Ratio
51.24
1Y Return
▲37.3%
Latest News

Trade setup for Wednesday: 15 things to know before opening bell
3 days ago on Moneycontrol
Change since news ▲2.31%
A short build-up was seen in 55 stocks, which were Abbott India, M&M Financial Services, ICICI Prudential Life Insurance Company, L&T Technology Services, and IRCTC.

Pharma Q2 Results Review - Splendid Quarter, Positive Momentum To Accelerate Ahead: ICICI Securities
2 weeks ago on Bloomberg Quint
Change since news ▲4.31%
Cipla, Aurobindo Pharma, Ajanta Pharma and Abbott India are our top picks in the space.

Abbott India trades lower after Q2 results, CLSA downgrades stock to outperform
4 weeks ago on Moneycontrol
Change since news ▲3.58%
Analysts at CLSA have downgraded the stock to outperform from Buy and have raised the target price to Rs 27,500 per share.
FAQs on Abbott India Ltd
How to buy Abbott India Ltd stocks?
You can easily buy the stocks/shares of Abbott India Ltd (ABBOTINDIA) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Abbott India Ltd?
The stock price of Abbott India Ltd as on 08 Dec 2023 is ₹22,858
What is the 52-week High and Low of Abbott India Ltd?
The 52-week high and low of Abbott India Ltd (ABBOTINDIA) is ₹24,744.25 and ₹19,900.
What is the PE and PB ratio of Abbott India Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Abbott India Ltd are 45.34 and 15.38 respectively.
What are the peers or stocks similar to Abbott India Ltd?
The peers or stocks similar to Abbott India Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Abbott India Ltd belong to?
Abbott India Ltd (ABBOTINDIA) belongs to the Pharmaceuticals sector.
What is the Market Cap of Abbott India Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Abbott India Ltd (ABBOTINDIA) is ₹49,029 Cr as of 08 Dec 2023
Can't decide whether or not to buy Abbott India Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.